In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

HIV vaccines have been in development for decades, but a long-lasting one has yet to be successful. The mRNA technology offers new opportunities because mRNA produces a more potent antibody response.

Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021.

Many people infected with HIV don’t develop those antibody levels, much less people exposed to the various attempted vaccines throughout the decades. But the hope is that an mRNA vaccine could ...